The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris

Kardiologia Polska

Volumn 72, Issue 1, 2014, Pages 34-41

  Aksu, Feyza ^a   Özçelik, Fatih ^a   Kunduracilar, Hakan ^a   Barutçu, Ahmet ^a   Yel, Mesih ^a   Ümit, Elif Gülsüm ^a   Altun, Armaǧan ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Acute coronary syndrome; Osteoprotegerin; Stable angina pectoris

Indexed keywords

OSTEOPROTEGERIN; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; FEMALE; GENSINI SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PREVALENCE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; ANGINA, STABLE; ANGINA, UNSTABLE; BLOOD; COMORBIDITY; MULTIVARIATE ANALYSIS;

ACUTE CORONARY SYNDROME; ANGINA, STABLE; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOPROTEGERIN; PREDICTIVE VALUE OF TESTS; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 84893149727     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.2014.0004     Document Type: Article

References (29)

1. Secci A, Wong N, Tang W et al. Electron beam computed tomographic coronary calcium as a predictor of coronary events: comparison of two protocols. Circulation, 1997; 96: 1122-1129.
2. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature, 2003; 423: 337-342.
3. Caidahl K, Ueland T, Aukrust P. Osteoprotegerin: a biomarker with many faces. Arterioscler Thromb Vasc Biol, 2010; 30: 1684-1686.
4. Venuraju SM, Yerramasu A, Corder R, Lahiri A. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am Coll Cardiol, 2010; 55: 2049-2061.
5. Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther, 2007; 9 (Suppl): S1-S7.
6. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res, 2004; 95: 1046-1057.
7. Brandstrom H, Bjorkmann T, Ljunggren O. Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells. Biochem Biophys Res Commun, 2001; 280: 831-835.
8. Mizuno A, Amizuka N, Irie K et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory actor/osteoprotegerin. Biochem Biophys Res Commun, 1998; 247: 610-615.
9. Malyankar UM, Scatena M, Suchland KL et al. Osteoprotegerin is an alpha vbeta 3-induced, NF-kappaB-dependent survival factor for endothelial cells. J Biol Chem, 2000; 275: 20959-20962.
10. Hak AE, Pols HA, van Hemert AM et al. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol, 2000; 20: 1926-1931.
11. Kado DM, Browner WS, Blackwell T et al. Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res, 2000; 15: 1974-1980.
12. Giaginis C, Papadopouli A, Zira A et al. Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor kB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis. Med Sci Monit, 2012; 18: 597-604.
13. Jono S, Ikari Y, Shioi A et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation, 2002; 106: 1192-1194.
14. Schoppet M, Sattler AM, Schaefer JR et al. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab, 2003; 88: 1024-1028.
15. Avignon A, Sultan A, Piot C et al. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. Diabetes Care, 2005; 28: 2176-2180.
16. Palazzuoli A, Rizzello V, Calabrò A et al. Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: Relation to coronary artery narrowing and plaques number. Clin Chim Acta, 2008; 391: 74-79.
17. Braunwald E ed. Coronary arteriography. In: Heart disease. WB Saunders, Philadelphia 1980.
18. Morena M, Dupuy AM, Jaussent I et al. A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. Nephrol Dial Transplant, 2009; 24: 3389-3397.
19. Anand DV, Lahiri A, Lim E et al. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. J Am Coll Cardiol, 2006; 47: 1850-1857.
20. Budoff MJ, Achenbach S, Blumenthal RS et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation, 2006; 114: 1761-1791.
21. Panizo S, Cardus A, Encinas M et al. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res, 2009; 104: 1041-1048.
22. Rackley CE. Pathogenesis of atherosclerosis. Atherosclerosis, 2009; 202: 167-174.
23. Bucay N, Sarosi I, Dunstan CR et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev, 1998; 12: 1260-1268.
24. Shamsara J, Ramezani M, Mohammadpour A H. The RANKL: osteoprotegerin (OPG) ratio as a new biomarker for coronary artery disease. Iran J Med Hypotheses Ideas, 2009; 3: 1-7.
25. Anand DV, Lahiri A, Lim E et al. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. J Am Coll Cardiol, 2006; 47: 1850-1857.
26. Soufi M, Schoppet M, Sattler AM et al. Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab, 2004; 89: 3764-3768.
27. Rhee EJ, Oh KW, Jung CH et al. The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans. Clin Endocrinol (Oxf), 2006; 64: 689-697.
28. Celczyńska-Bajew L, Horst-Sikorska W, Bychowiec B et al. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density. Kardiol Pol, 2011; 69: 573-578.
29. Choe WS, Kim HL, Han JK et al. Association between OPG, RANK and RANKL gene polymorphisms and susceptibility to acute coronary syndrome in Korean population. J Genet, 2012; 91: 87-89.